Morning Research: Vertex Pharma Inc., Orexigen Therapeutics Inc., MAKO
Surgical Corp., and Alere Inc.
LONDON, September 24, 2013
LONDON, September 24, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
On Monday, September 23, 2013, the S&P 500 ended the day at 1,701.84, down
0.47%; the Dow Jones Industrial Average closed at 15,401.38, down 0.32%; and
the NASDAQ Composite finished at 3,765.29, down 0.25%. Shares in the
healthcare sector ended on a mixed note, even as the broader market posted
losses. The major movers in the sector included Vertex Pharmaceuticals Inc.
(NASDAQ: VRTX), Orexigen Therapeutics Inc. (NASDAQ: OREX), MAKO Surgical
Corporation (NASDAQ: MAKO), and Alere Inc. (NYSE: ALR). AAAResearchReports.com
has released full comprehensive research on VRTX, OREX, MAKO, and ALR. These
free technical analyses can be downloaded by signing up at:
Shares in Vertex Pharmaceuticals Inc. edged lower on Monday, extending the
losses from the previous trading session. The company's shares ended the day
at $75.59, which is 0.74% lower than the previous day's price of $76.15. The
company's shares vacillated between $74.94 and $76.74 during the trading
session. A total of 3.25 million shares were traded, which is above the daily
average volume of 2.14 million. Despite Monday's losses, Vertex
Pharmaceuticals Inc.'s stock is trading above its 200-day moving average of
$64.91. Additionally, the company's shares have fallen by 0.51% in the
previous three months, compared to a gain of 6.87% in the S&P 500 during the
same period. Download free report on VRTX upon registration at:
Orexigen Therapeutics Inc.'s stock gained 0.99% on Monday, reversing some of
the losses from the previous trading session. The company's shares fluctuated
between $6.53 and $6.70 before finishing the day at $6.61. A total of 0.92
million shares were traded, which is below the daily average volume of 1.21
million. The company's shares have gained 9.44% in the previous three months,
outperforming the S&P 500 which has gained 6.87% during the same period.
Furthermore, Orexigen Therapeutics Inc.'s stock is trading above its 200-day
moving average of $6.18. OREX technical report can be accessed for free by
signing up at:
On Monday, MAKO Surgical Corp.'s stock edged lower to close at $16.28, down
0.49% from the previous day's closing price of $16.36. The company's shares
oscillated between $15.94 and $16.49 during the trading session. A total of
0.46 million shares were traded, which is below the daily average volume of
0.84 million. Despite Monday's pullback, the company's shares have surged
10.97% in the last one month and 38.44% in the previous three months,
outperforming the S&P 500 which has gained 2.30% and 6.87% during the
respective periods. Moreover, MAKO Surgical Corp.'s stock is trading above its
50-day and 200-day moving averages of $14.55 and $12.44, respectively. The
free report on MAKO can be downloaded by signing up now at:
Alere Inc.'s stock edged higher on Monday, reversing some of the losses from
the previous trading session. The company's shares traded between $31.36 and
$31.98 before finishing the day 0.86% higher at $31.68. A total of 0.63
million shares were traded, which is at par with the daily average volume. The
company's shares have surged 27.54% in the previous three months, compared to
a gain of 6.87% in the S&P 500 during the same period. Further, Alere Inc.'s
stock is trading above its 50-day and 200-day moving averages of $31.16 and
$25.43, respectively. A free report on ALR can be accessed by registering at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are
only human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider represented by Ananya Ghosh, CFA, has
only reviewed the information provided by Equity News Network in this article
or report according to the Procedures outlined by Equity News Network. Equity
News Network is not entitled to veto or interfere in the application of such
procedures by the outsourced provider to the articles, documents or reports,
as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA
SOURCE AAA Research Reports
Contact: Media Contact: Peter F. Jones, +1-(646)396-9126,
Press spacebar to pause and continue. Press esc to stop.